Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Health Evaluation of Abilify Long-term Therapy
NCT00520650Phase 4Completed
- Sponsor
- Otsuka Holdings
- Start
- Aug 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aripiprazole in schizophrenia, schizoaffective disorder, sponsored by Otsuka Holdings. Started Aug 2006; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00520650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00520650.